Parameter Included: 1
-
ANTI-CCP (CCP) In Jaipur
Anti-CCP (anti-cyclic citrullinated peptide) antibodies are autoantibodies that are specific to rheumatoid arthritis (RA)
-
Price : ₹1100.00
Reliable, Ashirwad Hospital, Jaipur
RDCAHP
: Reliable, Ashirwad Hospital, Jaipur
Reliable, Durgapura, Jaipur
RDCDUR
: Reliable, Durgapura, Jaipur
Reliable, Shri Hospital, Jaipur
RDCSHJ
: Reliable, Shri Hospital, Jaipur
Reliable, Corporate Office
RDCCOR
: Reliable, Corporate Office
Reliable, Phcc, Jaipur
RDCPHJ
: Reliable, Phcc, Jaipur
Reliable, Agra Road, Jaipur
RDCARJ
: Reliable, Agra Road, Jaipur
Parameter Included:
1
Sample Collection
Free
Doctor Consultation
Free
Test booked
100+
Report Time
24 Hours
Fasting Time
Test Recommended
Male, Female
Recommended age
5-99 Years
This test looks for anti cyclic citrullinated peptide (CCP) antibodies in the blood, which are a type of autoantibodies that can cause disease by attacking the body's healthy cells. If CCP antibodies are found in your blood, it can be a sign of rheumatoid arthritis (RA). This test is advised if you show symptoms of rheumatoid arthritis-like joint pain, low-grade fever, joint swelling, and fatigue. CCP antibodies are found in more than 75% of people who have rheumatoid arthritis. As rheumatoid arthritis can be difficult to diagnose, especially in its early stages, other tests such as X-ray and C reactive protein tests are also recommended.
These antibodies target citrullinated proteins, which are proteins that have undergone a modification called citrullination. In individuals with RA, the immune system mistakenly creates anti-CCP antibodies that attack healthy tissues, leading to inflammation and joint damage.
The presence of anti-CCP antibodies in the blood can help in the diagnosis of RA, as they have been found to be highly specific to this condition. Anti-CCP testing is often performed alongside other blood tests, such as rheumatoid factor (RF) testing, to aid in the diagnosis and differentiation of RA from other types of arthritis.
Research has shown that the presence of anti-CCP antibodies in individuals with early symptoms of joint pain or stiffness indicates a higher likelihood of developing more severe and persistent RA. Therefore, anti-CCP testing can be valuable in identifying patients who may benefit from early intervention and treatment.
Monitoring anti-CCP antibody levels over time can also provide information on disease activity and response to treatment in individuals with RA. High levels of anti-CCP antibodies have been associated with more aggressive disease and a higher risk of joint damage.
In summary, anti-CCP antibodies are autoantibodies specific to rheumatoid arthritis. Testing for anti-CCP antibodies can aid in the diagnosis of RA, help assess disease severity, and guide treatment decisions. It is a valuable tool in rheumatology clinics for identifying and managing this chronic autoimmune disease.
